572 related articles for article (PubMed ID: 7523772)
1. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
[TBL] [Abstract][Full Text] [Related]
2. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Hermans WR; Foley DP; Rensing BJ; Serruys PW
Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Hermans WR; Rensing BJ; Foley DP; Deckers JW; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
J Am Coll Cardiol; 1992 Oct; 20(4):767-80. PubMed ID: 1388181
[TBL] [Abstract][Full Text] [Related]
4. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.
Faxon DP
J Am Coll Cardiol; 1995 Feb; 25(2):362-9. PubMed ID: 7829789
[TBL] [Abstract][Full Text] [Related]
5. Luminal narrowing after percutaneous transluminal coronary angioplasty. A multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin.
Melkert R; Violaris AG; Serruys PW
J Invasive Cardiol; 1994 Jun; 6(5):160-71. PubMed ID: 10155065
[TBL] [Abstract][Full Text] [Related]
6. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
[TBL] [Abstract][Full Text] [Related]
7. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
[TBL] [Abstract][Full Text] [Related]
8. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
Rensing BJ; Hermans WR; Vos J; Tijssen JG; Rutch W; Danchin N; Heyndrickx GR; Mast EG; Wijns W; Serruys PW
Circulation; 1993 Sep; 88(3):975-85. PubMed ID: 8353925
[TBL] [Abstract][Full Text] [Related]
9. Effect of cilazapril on vascular restenosis after percutaneous transluminal coronary angioplasty.
Yamabe T; Imazu M; Yamamoto H; Ueda H; Hattori Y; Hayashi Y; Sekiguchi Y; Ito M; Yamakido M
Coron Artery Dis; 1995 Jul; 6(7):573-9. PubMed ID: 7582196
[TBL] [Abstract][Full Text] [Related]
10. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR).
Berger PB; Holmes DR; Ohman EM; O'Hanesian MA; Murphy JG; Schwartz RS; Serruys PW; Faxon DP
J Am Coll Cardiol; 1996 Jan; 27(1):1-7. PubMed ID: 8522681
[TBL] [Abstract][Full Text] [Related]
11. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
Foley DP; Melkert R; Serruys PW
Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
[TBL] [Abstract][Full Text] [Related]
12. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
Violaris AG; Melkert R; Serruys PW
Circulation; 1995 Apr; 91(8):2140-50. PubMed ID: 7697842
[TBL] [Abstract][Full Text] [Related]
13. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitor in a human model of restenosis. MERCATOR ("Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis") Study Group.
Heyndrickx GR
Basic Res Cardiol; 1993; 88 Suppl 1():169-82. PubMed ID: 8357332
[No Abstract] [Full Text] [Related]
15. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery.
Adelman AG; Cohen EA; Kimball BP; Bonan R; Ricci DR; Webb JG; Laramee L; Barbeau G; Traboulsi M; Corbett BN
N Engl J Med; 1993 Jul; 329(4):228-33. PubMed ID: 8316267
[TBL] [Abstract][Full Text] [Related]
16. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
[TBL] [Abstract][Full Text] [Related]
17. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
[TBL] [Abstract][Full Text] [Related]
18. Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids.
Jorgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Høstmark AT; Thaulow E
Eur Heart J; 1999 Oct; 20(19):1407-14. PubMed ID: 10487801
[TBL] [Abstract][Full Text] [Related]
19. Angiographic risk factors of luminal narrowing after coronary balloon angioplasty using balloon measurements to reflect stretch and elastic recoil at the dilation site. The CARPORT Study Group.
Rensing BJ; Hermans WR; Vos J; Beatt KJ; Bossuyt P; Rutsch W; Serruys PW
Am J Cardiol; 1992 Mar; 69(6):584-91. PubMed ID: 1536105
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
Karsch KR; Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia EJ; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R
J Am Coll Cardiol; 1996 Nov; 28(6):1437-43. PubMed ID: 8917255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
